
FDA Approves New Treatments: Oral Semaglutide & Lupus Nephritis Drug
The FDA has recently approved new treatments for two significant health challenges: cardiovascular risk reduction in type 2 diabetes and lupus nephritis. Learn about the potential benefits of these advancements and what they mean for patient care.





